Biomarkers in Diabetic Foot
- 14 January 2026
- journal article
- review article
- Published by Elsevier in Clinics in Podiatric Medicine and Surgery
- Vol. 43 (2) , 195-209
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK131261-S3)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK119083)
This publication has 47 references indexed in Scilit:
- Relationship Between Oxidative Stress and Severity of Diabetic Foot Ulcers Among Patients With Type‐2 Diabetes Mellitus in Japan: A Cross‐Sectional StudyHealth Science Reports, 2025
- Glycemic control and diabetic foot ulcer outcomes: A systematic review and meta-analysis of observational studiesJournal of Diabetes and its Complications, 2020
- Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed reviewReviews in Endocrine and Metabolic Disorders, 2019
- IL-6 signalling pathways and the development of type 2 diabetesInflammopharmacology, 2018
- Tumor Necrosis Factor‐Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes MellitusJournal of Cellular Biochemistry, 2017
- Role of procalcitonin in infected diabetic foot ulcerDiabetes Research and Clinical Practice, 2017
- Association Between Tumor Necrosis Factor-α and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: a Meta-AnalysisMolecular Neurobiology, 2016
- Diabetes Mellitus and InflammationCurrent Diabetes Reports, 2013
- Inflammation and type 2 diabetesDiabetes & Metabolism, 2012
- Fifty percent area reduction after 4 weeks of treatment is a reliable indicator for healing—analysis of a single-center cohort of 704 diabetic patientsJournal of Diabetes and its Complications, 2009